1. Home
  2. ALLT vs DNA Comparison

ALLT vs DNA Comparison

Compare ALLT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$10.30

Market Cap

506.5M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.67

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
DNA
Founded
1996
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
506.5M
562.3M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ALLT
DNA
Price
$10.30
$9.67
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$13.25
$10.50
AVG Volume (30 Days)
417.4K
870.2K
Earning Date
02-24-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$98,512,000.00
$180,606,000.00
Revenue This Year
$12.08
N/A
Revenue Next Year
$12.38
$3.07
P/E Ratio
$478.96
N/A
Revenue Growth
7.51
N/A
52 Week Low
$4.37
$5.00
52 Week High
$11.92
$17.58

Technical Indicators

Market Signals
Indicator
ALLT
DNA
Relative Strength Index (RSI) 52.26 56.20
Support Level $10.70 $8.82
Resistance Level $11.04 $10.42
Average True Range (ATR) 0.59 0.53
MACD -0.05 0.09
Stochastic Oscillator 39.46 70.51

Price Performance

Historical Comparison
ALLT
DNA

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: